Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8341-8350
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8341
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8341
Table 1 Major proposed interventions for nonalcoholic fatty liver disease
| Lifestyle intervention |
| Calorie restriction |
| Mediterranean diet |
| Exercise |
| Medication |
| Weight loss drugs |
| Orlistat |
| Sibutramine |
| Antidiabetics |
| Metformin |
| Pioglitazone |
| DPP IV inhibitors |
| GLP-1 receptors agonists |
| Antioxidants |
| Vitamin E |
| Statins |
| Pravastatin |
| Pitavastatin |
| Atorvastatin |
| Rosuvastatin |
| PUFA |
| Vitamin D |
| UDCA |
| Probiotics |
| Berberine |
| Silymarin |
| Silybin |
| Bariatric surgery |
- Citation: Ben MD, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8341-8350
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8341.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8341